Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase

被引:109
作者
De La Rosa, Martha [1 ]
Kim, Hong Woo [1 ]
Gunic, Esmir [1 ]
Jenket, Cheryl [1 ]
Boyle, Uyen [1 ]
Koh, Yung-hyo [1 ]
Korboukh, Ilia [1 ]
Allan, Matthew [1 ]
Zhang, Weijian [1 ]
Chen, Huanming [1 ]
Xu, Wen [1 ]
Nilar, Shahul [1 ]
Yao, Nanhua [1 ]
Hamatake, Robert [1 ]
Lang, Stanley A. [1 ]
Hong, Zhi [1 ]
Zhang, Zhijun [1 ]
Girardet, Jean-Luc [1 ]
机构
[1] Valeant Res & Dev, Costa Mesa, CA 92626 USA
关键词
antiviral; HIV-1; NNRTI; triazole; K103N; Y181C; Y188L;
D O I
10.1016/j.bmcl.2006.06.048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 1,2,4-triazoles was synthesized and tested against several NNRTI-resistant HIV-1 isolates. Several of these compounds exhibited potent antiviral activities against efavirenz- and nevirapine-resistant viruses, containing K103N and/or Y181C mutations or Y188L mutation. Triazoles were first synthesized from commercially available substituted phenylthio-semicarbazides, then from isothiocyanates, and later by condensing the desired substituted anilines with thiosemicarbazones. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4444 / 4449
页数:6
相关论文
共 12 条
[1]  
ANDREWS CW, 2001, Patent No. 0117982429
[3]   Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future [J].
De Clercq, E .
CHEMISTRY & BIODIVERSITY, 2004, 1 (01) :44-64
[4]   Antiviral drugs in current clinical use [J].
De Clercq, E .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (02) :115-133
[5]  
HEINEMANN U, 1988, Patent No. 3709263A1
[6]  
LYN Y, 1980, J HETEROCYCLIC CHEM, V17, P1077
[7]  
MALBEC F, 1984, J HETEROCYCLIC CHEM, V21, P1689, DOI 10.1002/jhet.5570210624
[8]   New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections [J].
Pauwels, R .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (05) :437-446
[9]  
PESSON M, 1961, CR HEBD ACAD SCI, V253, P285
[10]   Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4+ T cells [J].
Popik, W ;
Alce, TM ;
Au, WC .
JOURNAL OF VIROLOGY, 2002, 76 (10) :4709-4722